Brand Recall Hub
Variant Recalls in Canada
5 recalls found for Variant. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.
5 Variant Recalls
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
New safety information - COVID
View recall details →
Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant
New safety information - COVID
View recall details →
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
COVID - Product safety
View recall details →
VARIANT NBS Newborn Screening System - Sickle Cell Program (2020-02-27)
Medical devices
View recall details →
MiSeqDx Cystic Fibrosis 139-Variant Assay (2018-02-13)
Medical devices
View recall details →